Display Settings:

Format

Send to:

Choose Destination
Invest New Drugs. 1991 May;9(2):207-8.

A phase II clinical trial of diaziquone (AZQ) in the treatment of patients with recurrent leiomyosarcoma of the uterus. A Gynecologic Oncology Group study.

Author information

  • 1Department of Medicine, Rush-Presbyterian St. Luke's Medical Center, Chicago, IL.

Abstract

Based upon the activity observed in this trial, there does not appear to be a significant role for AZQ as a salvage agent for leiomyosarcoma of the uterus at the dose and schedule tested.

PMID:
1874603
[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Write to the Help Desk